Xeris Biopharma Holdings, Inc. Share Price
XERSXeris Biopharma Holdings, Inc. Stock Performance
Open $7.46 | Prev. Close $7.47 | Circuit Range N/A |
Day Range $7.40 - $7.62 | Year Range $3.15 - $10.07 | Volume 53,607 |
Average Traded $7.50 |
Xeris Biopharma Holdings, Inc. Share Price Chart
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Xeris Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
16-Jan-26 | $7.46 | $7.53 | +1.48% |
15-Jan-26 | $7.53 | $7.42 | -2.11% |
14-Jan-26 | $7.67 | $7.58 | -1.81% |
13-Jan-26 | $7.88 | $7.72 | -2.03% |
12-Jan-26 | $7.83 | $7.88 | -0.69% |
09-Jan-26 | $8.24 | $7.93 | -2.27% |
08-Jan-26 | $7.62 | $8.12 | +12.45% |
FAQs on Xeris Biopharma Holdings, Inc. Share Price
Can I buy Xeris Biopharma Holdings, Inc. shares in India?
What is the share price of Xeris Biopharma Holdings, Inc.?
What is the 5 year returns of Xeris Biopharma Holdings, Inc.?
What are the high & low stock price of Xeris Biopharma Holdings, Inc. today?
What is the 52-week high and low of Xeris Biopharma Holdings, Inc. stock?